15 Frequently Asked Questions : Bone Marrow Transplant Treatment in India for Canadian Patients

Q1 · Why Do Canadian Patients Consider Bone Marrow Transplant Treatment in India?

Canadian patients may consider India for BMT or stem-cell transplant evaluation when they are seeking access to specialised transplant centres, an additional specialist opinion or international treatment options.

Potential reasons include:

• Access to specialist haematologists and haemato-oncologists
• Dedicated bone marrow transplant units
• Autologous stem cell transplantation
• Allogeneic stem cell transplantation
• Haploidentical transplantation at selected centres
• Matched-related and selected unrelated-donor transplantation
• Advanced HLA and donor matching
• High-dose chemotherapy and conditioning treatment
• Advanced infection-control and supportive-care facilities
• Blood and platelet transfusion support
• Intensive-care facilities
• Long-term transplant follow-up
• Multidisciplinary cancer care
• Potentially lower private treatment costs than many international self-pay settings

BMT is a highly specialised treatment. Canadian Cancer Society notes that stem-cell transplantation may be used for selected cancers such as leukemia, lymphoma and multiple myeloma, while the type of transplant depends on the source of the stem cells.

The decision should be based on medical suitability, transplant expertise, disease-specific experience, donor availability, safety, expected recovery and total cost, rather than cost alone.

Q2 · What Is the Cost of Bone Marrow Transplant in India Compared with Canada?

Canadian patients should compare the complete treatment cost rather than looking only at the transplant procedure fee.

For Easy Comparison, Costs are mentioned in US Dollars (USD), Indian Rupees (INR) and Canadian Dollar (CAD).

These are planning exchange rates for comparison only. Actual currency conversion may vary.

Important Canadian cost note: Eligible Canadian residents generally receive medically necessary healthcare through provincial or territorial systems rather than paying a standard private BMT price. Therefore, the Canadian figures below are intended as indicative healthcare-cost comparison figures, not as a typical direct bill to a Canadian patient.

Exchange Rate Used for Planning

C$1 ≈ US$0.73  •  US$1 = INR 95

Indian 2026 estimates vary by transplant type and centre. Current published Indian estimates place autologous transplantation around ₹10–20 lakh, while allogeneic transplantation may commonly fall around ₹20–40 lakh or more, with unrelated-donor, haploidentical transplantation, complications and prolonged hospitalisation potentially increasing the total.

Canadian cost-effectiveness and reimbursement analyses also show that stem-cell transplantation can represent a substantial healthcare-system cost, with allogeneic transplantation generally costing considerably more than autologous transplantation.

These are indicative planning ranges and not fixed quotations. The actual cost should be confirmed after the transplant team reviews the patient's diagnosis, treatment history and donor requirements.

What Should Be Included in the Total Cost?

Canadian patients should ask whether the quotation includes:

• Haematologist consultation
• Transplant physician consultation
• Pre-transplant evaluation
• Bone marrow examination
• Blood tests
• Molecular and genetic testing
• HLA typing
• Donor matching
• Crossmatch testing where required
• Stem-cell mobilisation
• Stem-cell collection
• Stem-cell processing and cryopreservation
• Conditioning chemotherapy
• Radiation therapy where indicated
• Stem-cell infusion
• Hospital room
• Protective/isolation facilities
• ICU care where required
• Blood and platelet transfusions
• Antibiotics and antifungal medicines
• Antiviral medicines
• Immunosuppressive medicines for allogeneic transplantation
• Graft-versus-host disease prevention and treatment
• Infection management
• Management of transplant complications
• Doctor and specialist fees
• Nursing care
• Nutrition
• Physiotherapy and rehabilitation where required
• Follow-up consultations
• Additional investigations
• Accommodation near the hospital
• Flights
• Visa expenses
• Travel insurance
• Emergency and extended-stay expenses

Compare the Complete Treatment Cost

Treatment Journey in Canada

Diagnosis → Haemato-oncology consultation → Transplant eligibility assessment → Stem-cell collection / donor search → Conditioning → BMT/HSCT → Hospital recovery → Follow-up → Long-term monitoring

Treatment Journey in India

Medical records review → Specialist consultation → Transplant evaluation → Donor/HLA evaluation where applicable → Treatment planning → Stem-cell collection → Conditioning → Transplant → Engraftment and recovery → Follow-up → Return to Canada → Long-term monitoring

The financial comparison should include the entire treatment and recovery journey, not just the transplant procedure.

Compare the full planned treatment journey, not only the surgery quotation.

Q3 · Which Indian Cities Are Best for Bone Marrow Transplant for Canadian Patients?

The right Indian city depends on the patient's diagnosis, transplant type, disease status, specialist team, donor requirements, transplant infrastructure, infection-control facilities and long-term follow-up—not simply the lowest treatment cost.

The final city should be selected according to the patient's medical condition and the hospital and

Q4 · Which Hospitals in India Provide Bone Marrow Transplant Treatment?

Canadian patients should select a hospital based on its dedicated BMT programme, transplant-team experience, disease-specific expertise, infection-control facilities, ICU support, blood-bank services and long-term follow-up capabilities.

Canadian patients should verify that the selected hospital currently provides the required type of transplant for the patient's specific disease before making travel arrangements.

Q5 · What Types of Bone Marrow Transplant Treatments Are Available in India?

The appropriate transplant type depends on the disease, treatment response, overall health and source of the stem cells.

Autologous Stem Cell Transplant

In an autologous transplant, the patient's own blood-forming stem cells are collected and stored before high-dose treatment and then returned after conditioning therapy.

It is commonly used in selected patients with conditions such as:

• Multiple myeloma
• Certain lymphomas
• Selected other cancers

For multiple myeloma, autologous transplantation is the most common type of stem-cell transplant used in eligible patients.

Allogeneic Stem Cell Transplant

In an allogeneic transplant, stem cells come from another person.

The donor may be:

• A matched sibling
• Another related donor
• A matched unrelated donor
• A haploidentical or half-matched donor
• Another appropriate donor source depending on the clinical situation

Allogeneic transplantation may be used for selected patients with:

• Acute leukemia
• Myelodysplastic syndromes
• Certain lymphomas
• Other blood disorders
• Selected inherited or marrow-failure disorders

Haploidentical / Half-Matched Transplant

A haploidentical transplant uses a donor who is partially matched to the recipient.

It can expand donor availability when a fully matched donor is not available, but requires specialised transplant expertise.

Reduced-Intensity / Mini Transplant

Reduced-intensity conditioning uses lower-intensity chemotherapy and/or radiation before an allogeneic transplant. It may be considered for selected patients who may not tolerate standard conditioning.

Tandem Autologous Transplant

In selected conditions, two planned autologous transplants may be performed using previously collected stem cells.

Syngeneic Transplant

This uses stem cells from an identical twin and is uncommon.

Canadian Cancer Society identifies autologous, allogeneic, reduced-intensity and syngeneic transplantation among the major transplant approaches.

Q6 · How Can Canadian Patients Get a Bone Marrow Transplant Quotation From India While Abroad?

Canadian patients can begin the transplant evaluation process while still in Canada by providing complete medical records.

Recommended Medical Documents

• Complete diagnosis
• Bone marrow biopsy report
• Bone marrow aspiration report
• Flow cytometry
• Cytogenetic reports
• Molecular/genetic reports
• PET-CT/CT/MRI reports where applicable
• Complete blood counts
• Kidney and liver function tests
• Previous pathology reports
• Previous chemotherapy records
• Radiation-treatment records
• Previous transplant records
• Current medication list
• Discharge summaries
• Infection history
• Transfusion history
• Doctor's referral letter
• Current disease-status assessment

For Allogeneic Transplant

Where a donor is available, provide available information about:

• Donor age
• Relationship
• Blood group
• HLA information
• Medical history
• Previous illnesses
• Current medications

The transplant centre will conduct its own donor evaluation and confirm whether the donor is appropriate.

The quotation should clearly identify:

• Recipient evaluation
• Donor evaluation
• Stem-cell collection
• Stem-cell processing
• Conditioning
• Transplant infusion
• Hospitalisation
• Protective isolation
• ICU care if required
• Blood products
• Medicines
• Infection management
• GVHD prevention/treatment
• Follow-up
• Possible additional costs

Q7 · Can Canadian Patients Get a Second Opinion From an Indian Bone Marrow Transplant Specialist?

Yes. A specialist second opinion may be useful when:

• A transplant has been recommended
• The patient is unsure whether transplantation is necessary
• The disease has relapsed
• The disease has not responded adequately to treatment
• A donor is unavailable
• A haploidentical transplant is being considered
• A matched unrelated donor is being considered
• The patient has significant other health conditions
• Multiple treatment options are available
• The patient wants to compare transplant strategies

The specialist may review:

• Exact diagnosis
• Disease subtype
• Molecular characteristics
• Current remission status
• Previous treatment
• Treatment response
• Relapse risk
• Age and general health
• Organ function
• Infection history
• Donor availability
• HLA matching
• Transplant risks

Patients should not stop chemotherapy, maintenance therapy or other prescribed treatment solely because of a remote second opinion.

Q8 · What Records, Stem Cell Information and Treatment Documents Should Canadian Patients Take Home From India?

BMT patients need detailed records because follow-up continues after returning to Canada.

Recipient Records

Request copies of

• Final diagnosis
• Transplant indication
• Pre-transplant assessment
• Bone marrow reports
• Molecular/genetic reports
• HLA information
• Conditioning regimen
• Stem-cell collection records
• Stem-cell processing records
• Transplant infusion record
• Operative/procedure documentation where applicable
• ICU summary
• Discharge summary
• Blood and platelet transfusion records
• Infection records
• Medication list
• Immunosuppression regimen
• GVHD records where applicable
• Rejection/graft-failure records where applicable
• Follow-up schedule

Donor Information

For allogeneic transplantation, ask for appropriate documentation regarding:

• Donor type
• HLA matching
• Stem-cell source
• Collection procedure
• Donor medical assessment
• Donor-related records that can legally be shared

Long-Term Follow-Up

Also obtain

• Recommended blood-test schedule
• Bone marrow monitoring plan
• Infection precautions
• Vaccination recommendations
• Medication instructions
• Warning signs requiring urgent medical attention
• Canadian specialist follow-up recommendations

Q9 · Are Advanced Bone Marrow Transplant Techniques and Technologies Available in India?

Selected Indian transplant centres offer advanced BMT and HSCT approaches.

These may include

• Advanced HLA typing
• High-resolution donor matching
• Haploidentical transplantation
• Matched unrelated donor transplantation
• Reduced-intensity conditioning
• High-dose conditioning
• Peripheral blood stem-cell transplantation
• Bone-marrow stem-cell collection
• Stem-cell cryopreservation
• Advanced infection monitoring
• Antimicrobial prophylaxis
• GVHD prevention and treatment
• Chimerism monitoring
• Minimal residual disease monitoring
• Blood and platelet support
• Advanced ICU care

Peripheral Blood Stem Cells

Stem cells can be collected from the bloodstream after mobilisation rather than directly from bone marrow.

This is now an important source of transplant stem cells.

Bone Marrow Collection

In selected situations, stem cells may be collected directly from bone marrow.

Donor Matching

HLA testing is important in allogeneic transplantation because donor-recipient compatibility influences transplant planning and risk.

Canadian patients should ask:

• Which stem-cell source is recommended?
• What donor type is being considered?
• Is HLA matching complete?
• Is a haploidentical donor appropriate?
• What conditioning regimen is planned?
• What infection-control facilities are available?
• What happens if graft failure occurs?
• How are GVHD and infections managed?
• What monitoring is available after transplantation?

Q10 · Does Canadian Healthcare or Travel Insurance Cover Bone Marrow Transplant Treatment in India?

Canadian patients should not assume that planned BMT treatment in India will be reimbursed by their provincial or territorial healthcare plan.

Canadian healthcare coverage is administered through provincial and territorial systems, and rules regarding planned treatment outside Canada can vary.

Patients should check their province or territory's requirements before travelling.

Travel Insurance

Travel insurance may have exclusions relating to:

• Cancer
• Blood disorders
• Bone marrow failure
• Planned transplantation
• Pre-existing medical conditions
• Chemotherapy
• Immunosuppression
• Post-transplant complications

Ask the insurer specifically about:

• Pre-existing conditions
• Planned BMT treatment
• Emergency hospitalisation
• ICU care
• Infection-related treatment
• Medical evacuation
• Repatriation
• Extended accommodation
• Flight changes

Unexpected Costs

Patients should also budget for:

• Extended hospitalisation
• ICU treatment
• Blood/platelet transfusions
• Infection treatment
• GVHD treatment
• Additional chemotherapy
• Additional investigations
• Extended accommodation
• Delayed return flights
• Additional medicines

Q11 · Can Bone Marrow Transplant Treatment Be Combined or Staged During One Trip?

BMT is generally a multi-stage treatment rather than a single procedure.

A typical treatment journey may include:

Medical records review → Specialist consultation → Transplant eligibility assessment → Donor evaluation where applicable → Stem-cell mobilisation/collection → Conditioning treatment → Stem-cell infusion → Engraftment → Hospital recovery → Early follow-up → Long-term monitoring

For an autologous transplant, the patient's own stem cells are collected before high-dose treatment.

For an allogeneic transplant, donor identification and compatibility testing must be completed before transplantation.

The patient may need to remain near the transplant centre for an extended period because complications can occur during the engraftment and early recovery period.

Canadian patients should ask:

• How long will the pre-transplant evaluation take?
• How long will stem-cell collection take?
• Is inpatient admission required?
• How long is conditioning expected to last?
• How long is the expected hospital stay?
• How long should the patient remain near the transplant hospital?
• Is a caregiver required?
• When can the patient safely return to Canada?
• Which follow-up tests must be completed before departure?
• Can follow-up be transferred to a Canadian haematologist?

Q12 · What About Medical Visa, Flights and Hospital Admission for Bone Marrow Transplant in India?

Canadian patients travelling to India for planned BMT treatment should arrange the appropriate medical travel documentation and visa requirements before departure.

Before Travel

Prepare

• Valid passport
• Appropriate medical visa/documentation
• Hospital treatment confirmation
• Complete medical records
• Bone marrow and pathology reports
• Molecular/genetic reports
• Previous treatment records
• Current medication list
• Transplant plan
• Donor information where applicable
• Travel insurance details
• Accommodation arrangements
• Emergency contact information

Flights Patients receiving intensive chemotherapy or preparing for transplantation may have increased infection and bleeding risks.

The treating transplant team should determine whether the patient is medically fit to fly.

Patients should avoid booking a rigid return flight before the transplant team provides an expected recovery and discharge plan.

Hospital Admission

The hospital may arrange:

• Haematology consultation
• Transplant evaluation
• Additional diagnostic testing
• HLA/donor assessment
• Stem-cell collection
• Conditioning therapy
• Transplant admission
• Stem-cell infusion
• Engraftment monitoring
• Infection management
• Discharge planning

Q13 · How Long Should Canadian Patients Stay in India After Bone Marrow Transplant?

The length of stay varies considerably depending on:

• Transplant type
• Underlying disease
• Conditioning regimen
• Age
• Overall health
• Infection risk
• Engraftment
• GVHD
• Other complications

BMT is a complex treatment that generally requires close monitoring in a specialised transplant centre.

Canadian Cancer Society notes that stem-cell transplantation carries significant risks and should be performed in a specialised transplant centre or hospital.

Autologous Transplant

Patients generally undergo:

Stem-cell collection → Conditioning → Stem-cell infusion → Engraftment → Recovery → Discharge → Follow-up

Allogeneic Transplant

The recovery period can be more complex because patients require monitoring for:

• Infection
• GVHD
• Graft failure
• Blood-count recovery
• Organ complications
• Medication effects

Before Flying Back to Canada

The transplant team should confirm:

• Adequate blood-count recovery
• Stable clinical condition
• No uncontrolled infection
• No major unresolved complication
• Medication plan
• Follow-up arrangements
• Fitness to fly
• Airline requirements
• Emergency plan during travel

Patients should not book a fixed return flight until their transplant team confirms that travel is medically appropriate.

Q14 · What Rehabilitation and Follow-Up Care Will Canadian Patients Need After Bone Marrow Transplant?

Follow-up after BMT is an important part of treatment.

Patients may require

• Complete blood counts
• Kidney and liver function tests
• Bone marrow assessments
• Molecular testing
• Minimal residual disease monitoring where appropriate
• Chimerism testing after allogeneic transplant
• Infection monitoring
• Medication monitoring
• GVHD assessment
• Vaccination planning
• Nutritional support
• Physiotherapy
• Fatigue management
• Psychological support
• Long-term cancer surveillance

After Autologous Transplant

Follow-up focuses on

• Disease response
• Blood-count recovery
• Infection prevention
• Organ function
• Treatment-related side effects
• Disease surveillance

After Allogeneic Transplant

Additional monitoring may be required for:

• Acute GVHD
• Chronic GVHD
• Infection
• Immune-system recovery
• Immunosuppressive medicines
• Organ complications
• Long-term transplant effects

Patients should obtain a complete transplant summary before leaving India and arrange follow-up with their Canadian haematologist or transplant centre.

Q15 · Should Canadian Patients Choose Bone Marrow Transplant in Canada or India?

There is no single answer that is appropriate for every patient.

Canada May Be Preferable When

• The patient already has access to a Canadian transplant centre
• The required transplant programme is available
• Long-term specialist follow-up is important
• The patient has complex medical needs
• The patient has an established haematology team
• International travel may increase medical risk
• The patient is already undergoing treatment and monitoring in Canada

India May Be Considered When

• The patient wants an additional transplant opinion
• A specialised transplant programme is being considered
• The patient wants to compare transplant centres
• A particular BMT team is being considered
• The patient wants to explore donor or transplant options
• Treatment cost and international treatment options are important considerations

Before Making the Final Decision

Canadian patients should compare:

• Exact diagnosis
• Disease status
• Previous treatment
• Transplant eligibility
• Autologous versus allogeneic transplantation
• Donor availability
• HLA matching
• Transplant-team expertise
• Disease-specific transplant experience
• Infection-control facilities
• ICU support
• Expected hospital stay
• Total treatment cost
• Healthcare and insurance coverage
• Travel requirements
• Emergency arrangements
• Long-term follow-up in Canada

The best destination is the one that provides an appropriate, safe and medically justified transplant pathway for the individual patient.